Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Systemic Inflammatory Response Syndrome | 6 | 2021 | 6653 | 0.77 | Why? |
| Insect Control | 1 | 2018 | 17 | 0.73 | Why? |
| Chikungunya virus | 2 | 2018 | 339 | 0.69 | Why? |
| Chikungunya Fever | 2 | 2018 | 345 | 0.65 | Why? |
| Mosquito Vectors | 1 | 2018 | 351 | 0.56 | Why? |
| Aedes | 1 | 2018 | 380 | 0.55 | Why? |
| Vaccination Coverage | 2 | 2019 | 1249 | 0.45 | Why? |
| United States Virgin Islands | 2 | 2018 | 8 | 0.24 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.20 | Why? |
| Outpatients | 3 | 2021 | 3417 | 0.19 | Why? |
| Insect Repellents | 1 | 2018 | 23 | 0.18 | Why? |
| Immunoglobulins, Intravenous | 2 | 2021 | 2705 | 0.18 | Why? |
| Vaccines | 1 | 2017 | 3692 | 0.18 | Why? |
| United States | 13 | 2021 | 46150 | 0.17 | Why? |
| Work | 1 | 2020 | 342 | 0.17 | Why? |
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2017 | 92 | 0.17 | Why? |
| Personnel, Hospital | 2 | 2020 | 2273 | 0.16 | Why? |
| Tennessee | 3 | 2021 | 243 | 0.15 | Why? |
| Syndrome | 1 | 2020 | 1310 | 0.15 | Why? |
| Glucocorticoids | 2 | 2021 | 4431 | 0.14 | Why? |
| Telecommunications | 1 | 2020 | 551 | 0.14 | Why? |
| Immunomodulation | 2 | 2021 | 1472 | 0.14 | Why? |
| Goals | 1 | 2017 | 335 | 0.14 | Why? |
| Protective Clothing | 1 | 2018 | 468 | 0.13 | Why? |
| Intensive Care Units, Pediatric | 1 | 2021 | 1098 | 0.13 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.13 | Why? |
| Patient Acuity | 1 | 2021 | 1755 | 0.13 | Why? |
| Family Characteristics | 3 | 2020 | 2551 | 0.13 | Why? |
| Regression Analysis | 1 | 2021 | 2484 | 0.13 | Why? |
| Human Migration | 1 | 2014 | 133 | 0.13 | Why? |
| Child | 9 | 2021 | 70012 | 0.12 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.12 | Why? |
| Child, Preschool | 7 | 2021 | 36283 | 0.12 | Why? |
| Health Facilities | 1 | 2021 | 1230 | 0.12 | Why? |
| Pneumonia, Viral | 10 | 2020 | 243684 | 0.11 | Why? |
| Coronavirus Infections | 10 | 2020 | 253789 | 0.11 | Why? |
| Stroke Volume | 1 | 2021 | 2153 | 0.11 | Why? |
| Adolescent | 11 | 2021 | 86841 | 0.11 | Why? |
| Contact Tracing | 2 | 2020 | 8448 | 0.10 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.10 | Why? |
| Immunization Schedule | 1 | 2017 | 1305 | 0.10 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.10 | Why? |
| Environmental Exposure | 1 | 2020 | 1558 | 0.10 | Why? |
| Logistic Models | 2 | 2021 | 9089 | 0.09 | Why? |
| Refugees | 1 | 2019 | 809 | 0.09 | Why? |
| Income | 1 | 2018 | 1564 | 0.09 | Why? |
| Male | 18 | 2021 | 367725 | 0.09 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 1645 | 0.09 | Why? |
| Antibodies, Viral | 5 | 2021 | 51949 | 0.09 | Why? |
| Immunization Programs | 2 | 2019 | 2006 | 0.09 | Why? |
| Female | 18 | 2021 | 380317 | 0.09 | Why? |
| Community-Acquired Infections | 1 | 2020 | 2328 | 0.09 | Why? |
| Ebolavirus | 1 | 2014 | 834 | 0.08 | Why? |
| Seroepidemiologic Studies | 5 | 2021 | 10017 | 0.08 | Why? |
| Symptom Assessment | 1 | 2020 | 4967 | 0.08 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.08 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.07 | Why? |
| Case-Control Studies | 2 | 2021 | 17671 | 0.07 | Why? |
| Humans | 22 | 2021 | 930598 | 0.07 | Why? |
| World Health Organization | 1 | 2017 | 4213 | 0.07 | Why? |
| Inpatients | 1 | 2020 | 5161 | 0.07 | Why? |
| Infant | 4 | 2021 | 30274 | 0.07 | Why? |
| Adult | 12 | 2021 | 244371 | 0.06 | Why? |
| Hemorrhagic Fever, Ebola | 1 | 2014 | 1475 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Ambulatory Care | 1 | 2020 | 4947 | 0.06 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.06 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.06 | Why? |
| Patient Acceptance of Health Care | 1 | 2019 | 5002 | 0.05 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.05 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.05 | Why? |
| Ambulatory Care Facilities | 2 | 2020 | 2063 | 0.05 | Why? |
| Academic Medical Centers | 2 | 2020 | 3088 | 0.04 | Why? |
| Inflammation | 1 | 2020 | 13255 | 0.04 | Why? |
| Biomarkers | 1 | 2021 | 23361 | 0.04 | Why? |
| Delivery of Health Care | 2 | 2021 | 15909 | 0.04 | Why? |
| Arthralgia | 1 | 2018 | 173 | 0.04 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.04 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.04 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.04 | Why? |
| Focus Groups | 1 | 2019 | 811 | 0.04 | Why? |
| Shock | 1 | 2021 | 1868 | 0.03 | Why? |
| Africa, Western | 1 | 2014 | 363 | 0.03 | Why? |
| Vaccination | 1 | 2019 | 19050 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2020 | 1316 | 0.03 | Why? |
| Bangladesh | 1 | 2019 | 1620 | 0.03 | Why? |
| Travel-Related Illness | 1 | 2020 | 1357 | 0.03 | Why? |
| Pandemics | 10 | 2020 | 389249 | 0.03 | Why? |
| Propensity Score | 1 | 2021 | 2690 | 0.03 | Why? |
| Combined Modality Therapy | 1 | 2021 | 3395 | 0.03 | Why? |
| Age Distribution | 1 | 2021 | 3567 | 0.03 | Why? |
| Vaccination Refusal | 1 | 2019 | 831 | 0.03 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Patient Care | 1 | 2021 | 1664 | 0.02 | Why? |
| Travel | 2 | 2020 | 7220 | 0.02 | Why? |
| Retrospective Studies | 1 | 2020 | 105322 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Incidence | 2 | 2021 | 25622 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2021 | 3129 | 0.02 | Why? |
| Cohort Studies | 2 | 2021 | 36005 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2021 | 7268 | 0.02 | Why? |
| Qualitative Research | 1 | 2019 | 4337 | 0.02 | Why? |
| Patient Discharge | 1 | 2021 | 5696 | 0.02 | Why? |
| Parents | 1 | 2019 | 2758 | 0.02 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.02 | Why? |
| Aged | 4 | 2020 | 215776 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2020 | 53120 | 0.02 | Why? |
| Socioeconomic Factors | 1 | 2020 | 8495 | 0.01 | Why? |
| Genomics | 1 | 2014 | 3118 | 0.01 | Why? |
| Epidemiological Monitoring | 1 | 2014 | 3493 | 0.01 | Why? |
| Fever | 1 | 2018 | 7795 | 0.01 | Why? |
| Risk Factors | 2 | 2020 | 71621 | 0.01 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.01 | Why? |
| Infant, Newborn | 1 | 2020 | 23105 | 0.01 | Why? |
| Cross Infection | 1 | 2020 | 8675 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2018 | 88759 | 0.01 | Why? |
Feldstein's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(124)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(328)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_